China’s seventh national organized centralized volume-based procurement for
medical consumables opens for bidding in Tianjin today. The round targets
gastrointestinal interventional consumables and includes 23 product types
covering GI polypectomy and biliary‑pancreatic intervention consumables.
Contract terms are about three years. Procurement rules have been optimized with
an emphasis on clinical stability and quality, and measures to curb internal
price competition and prevent bid collusion while accommodating diverse clinical
demand and industry quality development.